Introducing EMJ Innovations 2.1

Introducing EMJ Innovations 2.1

Innovations January 9, 2018 at 8:34 AM 0 comments

United Kingdom, January 09, 2018: The European Medical Journal is bringing the New Year in with a bang with the publication of EMJ Innovations 2.1. This edition is packed with all the most exciting upcoming medical innovations and ongoing research with a fantastic review of MEDICA 2017, which had a whoppingRead More

Introducing EMJ Gastroenterology 6.1

Introducing EMJ Gastroenterology 6.1

Gastroenterology December 14, 2017 at 9:09 AM 0 comments

United Kingdom, November 14, 2017: The European Medical Journal welcomes you to their annual publication of EMJ Gastroenterology, complete with its review of the 25th United European Gastroenterology (UEG) Week. The prestigious event took place in the Catalan capital of Barcelona, Spain, in the midst of a supercharged political atmosphere.Read More

Agendia Collaborates with Prestigious Cancer Center, Institut Curie, for MammaPrint® BluePrint® Breast Cancer Kit Co-Validation Study

Oncology December 5, 2017 at 4:44 PM 0 comments

Institut Curie is one of an increasing number of major European cancer centers to become a co-validation partner for the new NGS-based MammaPrint BluePrint Kit Irvine, CA, USA, Amsterdam, the Netherlands, and Paris, France, 05 December, 2017 – Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and InstituteRead More

New Data at the San Antonio Breast Cancer Symposium Demonstrate the Value of MammaPrint® and BluePrint® Across Breast Cancer Patient Populations

Oncology December 1, 2017 at 11:28 AM 0 comments

Irvine, CA, USA and Amsterdam, the Netherlands, 30 November, 2017 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces the presentation of extensive new data at the upcoming 2017 San Antonio Breast Cancer Symposium (SABCS), highlighting the value of its MammaPrint® 70-Gene Breast Cancer Risk-of-RecurrenceRead More

Introducing the European Medical Journal 2.4

Introducing the European Medical Journal 2.4

European Medical Journal November 30, 2017 at 9:51 AM 0 comments

United Kingdom, November 30, 2017: The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4. This eJournal contains a myriad of cutting-edge, peer-reviewed articles from a range of therapeutic areas, including oncology, hepatology, dermatology, and many more. In the spiritRead More

Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials

Oncology November 30, 2017 at 9:31 AM 0 comments

Maastricht, The Netherlands, 28 November, 2017 – Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need, today announced that it secured a €2.5 million grant from the European Commission’s Horizon 2020 programme. The funds will be usedRead More

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

Oncology, Reproductive Health November 30, 2017 at 9:26 AM 0 comments

Prague, Czech Republic, 28 November, 2017 – SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase II study testing DCVAC/OvCa in combination with standard of care chemotherapy for patients with ovarian cancer after first relapse. Based on positive signalsRead More

Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B

Uncategorized November 30, 2017 at 9:18 AM 0 comments

Orchard Therapeutics Announces Extension of its Collaboration with Manchester University to Include Sanfilippo Syndrome Type B London & Manchester, UK, 27 November, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, announces today that itRead More

UK Health ‘Innovation Hub’ Opens at Dell Medical School

UK Health ‘Innovation Hub’ Opens at Dell Medical School

Innovations November 21, 2017 at 9:09 AM 0 comments

9 November, 2017 – The Association of British Healthcare Industries (ABHI) and the Dell Medical School at The University of Texas at Austin are delighted to announce the establishment of the “ABHI Innovation Hub”. The creation of the Hub, a first for ABHI, will offer UK companies the opportunity to locate themselvesRead More

Introducing EMJ Dermatology 5.1

Introducing EMJ Dermatology 5.1

Dermatology November 2, 2017 at 9:58 AM 0 comments

United Kingdom, November 02, 2017: The European Medical Journal welcomes you to the 2017 edition of EMJ Dermatology, complete with a summary of the 26th European Academy of Dermatology and Venereology (EADV) congress, interviews with members of the highly esteemed EMJ Dermatology Editorial Board, abstracts from the EADV Congress, andRead More